Novanta Inc
NASDAQ:NOVT
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
American Express Co
NYSE:AXP
|
Financial Services
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Target Corp
NYSE:TGT
|
Retail
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
134.91
186.2
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Estee Lauder Companies Inc
NYSE:EL
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Church & Dwight Co Inc
NYSE:CHD
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
American Express Co
NYSE:AXP
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Target Corp
NYSE:TGT
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
Mueller Industries Inc
NYSE:MLI
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one NOVT stock under the Base Case scenario is 85.094 USD. Compared to the current market price of 169.825 USD, Novanta Inc is Overvalued by 50%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Novanta Inc
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for NOVT cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Novanta Inc. is a thriving technology company operating at the intersection of precision optics, advanced motion control, and industrial automation. Founded in 1978, the company has transformed itself over the decades, evolving from a niche player in the photonics industry into a robust provider of critical components and solutions that drive the growth of various sectors, including healthcare, life sciences, and automation. With a keen focus on innovation, Novanta develops products like high-performance lasers, vision systems, and motion control technologies that enable their customers to enhance productivity and precision in their applications. Their commitment to quality and performance h...
Novanta Inc. is a thriving technology company operating at the intersection of precision optics, advanced motion control, and industrial automation. Founded in 1978, the company has transformed itself over the decades, evolving from a niche player in the photonics industry into a robust provider of critical components and solutions that drive the growth of various sectors, including healthcare, life sciences, and automation. With a keen focus on innovation, Novanta develops products like high-performance lasers, vision systems, and motion control technologies that enable their customers to enhance productivity and precision in their applications. Their commitment to quality and performance has established Novanta as a trusted partner for many leading global brands, ensuring sustainable growth and strong industry positioning.
Investor confidence in Novanta is bolstered by its strategic emphasis on high-growth markets and a strong track record of profitability. The company's dedication to research and development has fostered a culture of continuous improvement, allowing it to adapt swiftly to changing market demands and technological advancements. As the demand for automation and high-precision solutions continues to surge globally, Novanta is well-positioned to capitalize on this trend. With a careful balance of organic growth and strategic acquisitions, Novanta is not just growing; it is building a portfolio that promises long-term value creation. For investors seeking exposure to the advancing technological landscape, Novanta Inc. represents a compelling opportunity, combining innovative prowess with a strong financial foundation and a bright growth trajectory in its core markets.
Novanta Inc. operates in the precision photonics and robotics sectors, focusing on providing essential components and solutions for various high-growth markets. Its core business segments include:
-
Advanced Photonics: This segment offers high-performance optics, lasers, and other photonic solutions, catering to industries such as medical devices, industrial laser systems, and semiconductor manufacturing. Novanta focuses on enabling precision applications that require advanced light manipulation and measurement.
-
Motion Control: Novanta’s motion control solutions include high-precision motion systems, motors, and controllers used in automation and robotics. This segment serves applications in medical equipment, such as surgical devices and imaging systems, as well as in industrial automation and robotics.
-
Medical Technologies: This segment integrates Novanta's products into medical equipment, particularly in surgical and diagnostic systems. The company provides solutions that enhance the performance and reliability of medical devices, facilitating better patient outcomes.
-
Industrial Automation: Novanta also targets the industrial sector with its advanced motion and photonics technologies, supporting a range of applications from manufacturing automation to packaging and quality control.
The company is positioned in markets that are experiencing strong growth due to trends such as increased healthcare demand, advancements in automation technologies, and the expanding applications of photonics in various industries. Its focus on innovation and high-quality performance enables it to maintain a competitive edge in these core segments.
Novanta Inc., a provider of photonics, precision motion, and advanced technologies, has several unique competitive advantages that help it stand out in its market. Here are some key advantages:
-
Strong Focus on Precision and Innovation: Novanta emphasizes high-performance and precision solutions, which are crucial for demanding applications in medical, industrial, and advanced technologies. Their commitment to R&D enables them to stay at the forefront of innovation.
-
Diverse Product Portfolio: Novanta offers a wide range of products, including laser systems, motion controllers, and optical components. This diversity allows them to serve multiple industries, reducing dependency on any single sector and enabling cross-selling opportunities.
-
Specialized Expertise: The company has built a deep expertise in its niche markets, particularly in medical devices and life sciences, where quality and reliability are critical. This specialization helps them establish strong relationships with customers who require high-standards products.
-
Global Presence with Local Support: Novanta has a worldwide presence, which allows it to support customers locally while leveraging global efficiencies in manufacturing and R&D. This balance enhances customer service and speeds up response times.
-
Strong Customer Relationships: Novanta focuses on long-term partnerships with its customers, tailoring solutions to meet specific needs. This customer-centric approach fosters loyalty and trust, making it difficult for competitors to penetrate these established relationships.
-
Intellectual Property and Proprietary Technology: The company holds numerous patents and possesses proprietary technologies that provide a significant barrier to entry for competitors. This intellectual property can translate into higher margins and market differentiation.
-
Scalable Operations: Novanta’s operational efficiencies and scalable business model enable them to adapt to changing market demands quickly. This flexibility allows them to optimize production and supply chain processes.
-
Commitment to Quality and Compliance: In sectors such as medical devices, compliance with regulatory standards is essential. Novanta's rigorous quality assurance processes and compliance capabilities give them an edge over rivals that may struggle with these requirements.
-
Sustainability Initiatives: As more companies focus on environmental responsibility, Novanta’s commitment to sustainable practices can be a distinguishing factor, appealing to customers who prioritize sustainability in their supply chains.
-
Robust Financial Health: Sound financial management and a strong balance sheet provide Novanta with the ability to invest in new technologies, acquire complementary businesses, and weather economic downturns better than some of its competitors.
In summary, Novanta Inc.'s competitive advantages center around its specialization, innovation, customer focus, and operational strengths, positioning it effectively against rivals in its industry.
As a professional business analyst, when assessing the risks and challenges that Novanta Inc might face, several factors can be taken into consideration, especially given the context of their business operations. Novanta specializes in precision core technology, which serves advanced medical and industrial applications. Here are some potential risks and challenges they may encounter:
-
Market Competition:
- The precision technology market is highly competitive. Novanta faces competition from both established players and new entrants, which could put pressure on pricing and market share.
-
Technological Advancements:
- Rapid technological changes may require Novanta to invest continuously in research and development (R&D) to keep pace with innovations. Failing to adopt new technologies or adapt product offerings could result in losing competitive advantage.
-
Supply Chain Vulnerabilities:
- Like many companies, Novanta may face disruptions in their supply chain due to geopolitical tensions, natural disasters, or global events such as pandemics. These disruptions can affect production costs and delivery timelines.
-
Regulatory Compliance:
- Operating in the medical device sector entails strict regulatory scrutiny. Non-compliance with FDA regulations and international standards could result in costly recalls or legal issues.
-
Economic Downturns:
- Economic downturns could impact the capital expenditures of customers in the medical and industrial sectors, leading to reduced demand for Novanta’s products.
-
Foreign Exchange Risks:
- If Novanta operates internationally, fluctuations in exchange rates could impact profitability, especially if foreign sales are significant.
-
Talent Acquisition and Retention:
- The ability to attract and retain skilled labor is crucial for maintaining innovation and operational effectiveness. Competition for talent is high in technology sectors, which may escalate payroll costs.
-
Integration of Acquisitions:
- If Novanta pursues growth through acquisitions, the successful integration of acquired companies and cultures may present challenges and could distract from core operations.
-
Intellectual Property Risks:
- As a player in a tech-heavy industry, Novanta must protect its intellectual property. Risks related to infringement or failure to secure patents can have severe financial repercussions.
-
Customer Concentration:
- If a significant portion of their revenue comes from a limited number of customers or sectors, economic fluctuations affecting these clients could pose a risk to overall revenue stability.
-
Cybersecurity Threats:
- As industries become more reliant on connected technologies, Novanta will need to invest in cybersecurity measures to protect sensitive data and maintain customer trust.
Mitigating these risks will require ongoing strategic planning, investment in innovation, and vigilant monitoring of market conditions. Prioritizing these challenges will be key to sustaining growth and achieving long-term objectives.
Revenue & Expenses Breakdown
Novanta Inc
Balance Sheet Decomposition
Novanta Inc
Current Assets | 436.9m |
Cash & Short-Term Investments | 92.7m |
Receivables | 177.3m |
Other Current Assets | 166.9m |
Non-Current Assets | 981.9m |
PP&E | 164.2m |
Intangibles | 792.5m |
Other Non-Current Assets | 25.2m |
Current Liabilities | 156.6m |
Accounts Payable | 68.7m |
Accrued Liabilities | 42.5m |
Other Current Liabilities | 45.4m |
Non-Current Liabilities | 520m |
Long-Term Debt | 455.9m |
Other Non-Current Liabilities | 64.2m |
Earnings Waterfall
Novanta Inc
Revenue
|
922.8m
USD
|
Cost of Revenue
|
-512.9m
USD
|
Gross Profit
|
409.9m
USD
|
Operating Expenses
|
-292.4m
USD
|
Operating Income
|
117.5m
USD
|
Other Expenses
|
-57.4m
USD
|
Net Income
|
60.1m
USD
|
Free Cash Flow Analysis
Novanta Inc
USD | |
Free Cash Flow | USD |
NOVT Profitability Score
Profitability Due Diligence
Novanta Inc's profitability score is 55/100. The higher the profitability score, the more profitable the company is.
Score
Novanta Inc's profitability score is 55/100. The higher the profitability score, the more profitable the company is.
NOVT Solvency Score
Solvency Due Diligence
Novanta Inc's solvency score is 56/100. The higher the solvency score, the more solvent the company is.
Score
Novanta Inc's solvency score is 56/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
NOVT Price Targets Summary
Novanta Inc
According to Wall Street analysts, the average 1-year price target for NOVT is 184.62 USD with a low forecast of 176.75 USD and a high forecast of 196.35 USD.
Dividends
Current shareholder yield for NOVT is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Novanta, Inc. engages in the provision of core technology solutions to healthcare and advanced industrial original equipment manufacturers. The company is headquartered in Bedford, Massachusetts and currently employs 2,700 full-time employees. The company has three segments: Photonics, Vision and Precision Motion. The Photonics segment designs, manufactures and markets photonics-based solutions, including laser scanning, laser beam delivery, carbon dioxide (CO2) laser, solid state laser, ultrafast laser and optical light engine products to customers worldwide. The Vision segment designs, manufactures and markets a range of medical grade technologies, including medical insufflators, pumps and related disposables; visualization solutions; wireless technologies, video recorders, and video integration technologies. The Precision Motion segment designs, manufactures and markets optical and inductive encoders, precision motors, servo drives and motion control solutions, integrated stepper motors, intelligent robotic end-of-arm technology solutions, air bearings, and air bearing spindles to customers worldwide.
Contact
IPO
Employees
Officers
The intrinsic value of one NOVT stock under the Base Case scenario is 85.094 USD.
Compared to the current market price of 169.825 USD, Novanta Inc is Overvalued by 50%.